Skip to main content
. 2023 Jul 24;34(11):1793–1811. doi: 10.1681/ASN.0000000000000199

Table 7.

Clinical trials on the anticoagulation effects of factor XI inhibitors in dialysis patients

Identifier Drugs Types Phases Status
NCT03358030 ISIS 416858 FXI antisense oligonucleotide Phase 2 Completed
NCT04534114 BAY2976217 FXI antisense oligonucleotide Phase 2 Completed
NCT04523220 BAY1213790 (osocimab) Monoclonal antibody to FXIa Phase 2 Completed

FXI, factor XI; FXIa, activated factor XI.